Avoro Capital Advisors LLC 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:05 am Sale |
2023-12-31 | 13G | United Therapeutics Corporation UTHR |
Avoro Capital Advisors LLC | 2,858,888 6.100% |
-6,112 (-0.21%) |
Filing |
| 2023-02-14 09:34 am Sale |
2022-12-31 | 13G | United Therapeutics Corporation UTHR |
Avoro Capital Advisors LLC | 2,865,000 6.300% |
-170,000 (-5.60%) |
Filing |
| 2022-02-11 10:02 am Purchase |
2021-12-31 | 13G | United Therapeutics Corporation UTHR |
Avoro Capital Advisors LLC | 3,035,000 6.700% |
185,000 (+6.49%) |
Filing |
| 2021-02-12 08:08 am Purchase |
2020-12-31 | 13G | United Therapeutics Corporation UTHR |
Avoro Capital Advisors LLC | 2,850,000 6.400% |
2,850,000 (New Position) |
Filing |